.@MartinShkreli explains why peptides will likely never get clinical trials, and says some drugs get stuck in a twilight zone where you know that a drug works, but also know it will never get FDA approval: "There's this edge case where you have a cosmeceutical, or something that doesn't quite fit the description of a disease to the FDA." "In some ways, you're sort of taking an unapproved, technically illegal substance and buying it off some shady third-party market." "Eventually, I think we need to find a way, just like we talked about prediction markets - you have these third markets where you can bet on what Trump's going to say in a speech. It's not a registered stock exchange, but it's also more than just you and me making a side bet."